OnCusp
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
433 Broadway, New York City, New York, 1...Phone Number
(646) 585-2168Website
www.oncusptx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About OnCusp
OnCusp Therapeutics is a global biopharmaceutical company translating a focused portfolio of first-in-class oncology assets from promising research into proven medicines. The company is led by a founding team that has deep experience in business development, clinical development and building start-up biopharmaceutical company.Explore more
OnCusp Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OnCusp your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if OnCusp had a recent Job posting/layoffs
Earning: See what the market has to say on OnCusp recently announced quarterly report
OnCusp, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at OnCusp
Product Launch: Get notified when OnCusp launches new products
Funding: Get notified immidiatlly once OnCusp has new funding data
Check if OnCusp has recently received funding, and reach out quickly before it becomes old news!
Check out if OnCusp is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined OnCusp as Masked Content
Find 3 more new buyers
Compare Similar Companies to OnCusp
Compare insights from companies similar to OnCusp, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
OnCusp
<$5M
1-10
Private
$125M
2020
Bing YuanCo-Founder & CEO & Chief Everything Officer & Humble Entrepreneur
Company Profile Activity
Activity Insights
OnCusp is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
OnCusp is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about OnCusp.
OnCusp financials insights
Gather financial insights about OnCusp, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$25M
2024
Series A
$100M
OnCusp Tech Stack
A closer look at the technologies used by OnCusp
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Event
Events, Engineering, Research & Development, Training, Machine Learning, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Chemical Engineering, Artificial Intelligence, Clinical Operations, Healthcare Technology, HR Operations, Operations
Funding
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OnCusp
Sign Up For FreeTo access detailed company insights
OnCusp Therapeutics is a global biopharmaceutical company translating a focused portfolio of first-in-class oncology assets from promising research into proven medicines. The company is led by a founding team that has deep experience in business development, clinical development and building start-up biopharmaceutical company.... Read More
